Status:
UNKNOWN
Nasal High Flow Therapy in the Paediatric Home Setting
Lead Sponsor:
Rabin Medical Center
Collaborating Sponsors:
Fisher and Paykel Healthcare
Conditions:
Respiratory Disease
Lung Diseases
Eligibility:
All Genders
Up to 18 years
Brief Summary
High flow nasal cannula (HFNC) therapy is non-invasive respiratory support designed to deliver a high flow of heated humidified air, with or without entrained oxygen, via specifically designed nasal p...
Detailed Description
High flow nasal cannula (HFNC) therapy is non-invasive respiratory support designed to deliver a high flow of heated humidified air, with or without entrained oxygen, via specifically designed nasal p...
Eligibility Criteria
Inclusion
- Any child who received HFNC
- Previously trialed CPAP and BiPaP and deemed not tolerated by patient.
Exclusion
- N/A
Key Trial Info
Start Date :
March 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04037839
Start Date
March 26 2019
End Date
December 1 2022
Last Update
September 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical Center of Israel
Petah Tikva, Israel, 49202